- Home
- NBIX vs RTO Comparison
NBIX vs RTO Comparison
Compare NBIX & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- RTO
- Stock Information
- Founded
- NBIX 1992
- RTO 1925
- Country
- NBIX United States
- RTO United Kingdom
- Employees
- NBIX N/A
- RTO N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- RTO Business Services
- Sector
- NBIX Health Care
- RTO Consumer Discretionary
- Exchange
- NBIX Nasdaq
- RTO Nasdaq
- Market Cap
- NBIX 14.4B
- RTO 12.0B
- IPO Year
- NBIX 1996
- RTO N/A
- Fundamental
- Price
- NBIX $140.02
- RTO $26.70
- Analyst Decision
- NBIX Strong Buy
- RTO Buy
- Analyst Count
- NBIX 17
- RTO 1
- Target Price
- NBIX $164.94
- RTO N/A
- AVG Volume (30 Days)
- NBIX 803.5K
- RTO 557.4K
- Earning Date
- NBIX 10-28-2025
- RTO 07-31-2025
- Dividend Yield
- NBIX N/A
- RTO 1.91%
- EPS Growth
- NBIX 2.97
- RTO N/A
- EPS
- NBIX 3.39
- RTO 0.13
- Revenue
- NBIX $2,509,900,000.00
- RTO $7,581,860,530.00
- Revenue This Year
- NBIX $20.79
- RTO $9.51
- Revenue Next Year
- NBIX $14.73
- RTO $3.07
- P/E Ratio
- NBIX $40.99
- RTO $200.03
- Revenue Growth
- NBIX 18.42
- RTO N/A
- 52 Week Low
- NBIX $84.23
- RTO $19.60
- 52 Week High
- NBIX $154.61
- RTO $27.96
- Technical
- Relative Strength Index (RSI)
- NBIX 53.84
- RTO 59.26
- Support Level
- NBIX $136.71
- RTO $26.48
- Resistance Level
- NBIX $140.73
- RTO $27.18
- Average True Range (ATR)
- NBIX 3.35
- RTO 0.37
- MACD
- NBIX -0.34
- RTO 0.01
- Stochastic Oscillator
- NBIX 72.66
- RTO 58.42
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About RTO Rentokil Initial plc
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.